Actualités Shield Therapeutics Plc - STX | Actions London Stock Exchange

Shield Therapeutics PLC Results of 2024 Annual General Meeting

Shield Therapeutics PLC 20 June 2024 Shield Therapeutics plc ("Shield" or the "Company" or the "Group") Results of 2024 Annual General...

TRADING UPDATES: NetScientific backs Wanda; Inspirit Energy wins deal

The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by A ...

Shield Therapeutics PLC New Drug Application for Accrufer® in South Korea

Shield Therapeutics PLC 28 May 2024 Shield Therapeutics plc ("Shield" or the "Company" or the "Group") Shield's Korean Partner files New...

Shield Therapeutics PLC Audited results for the year ended 31 Dec 2023

Shield Therapeutics PLC 10 May 2024 Shield Therapeutics plc ("Shield" or...

EARNINGS AND TRADING: Software Circle & Beximco report higher revenue

The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not sep ...

Shield Therapeutics PLC Business Update for Q1 2024

Shield Therapeutics PLC 30 April 2024 Shield Therapeutics plc ("Shield" or the "Company" or the "Group") Business Update for Q1 2024 and...

Shield Therapeutics PLC Notice of Results

Shield Therapeutics PLC 16 April 2024 Shield Therapeutics plc ("Shield" or the "Company" or the "Group") Notice of Results Investor...

Shield Therapeutics sinks as strong performance marred by data issues

Shield Therapeutics PLC on Wednesday said that it was expecting stellar results for 2023, but this success was oversh ...

Shield Therapeutics PLC Unaudited Full Year Trading Update

Shield Therapeutics PLC 21 February 2024 Shield Therapeutics plc ("Shield" or the "Company" or the "Group") Unaudited Full Year Trading...

IN BRIEF: Shield Therapeutics hires former Akili leader as new CFO

cs PLC - Commercial-stage pharmaceutical company focused on iron deficiency product Accrufer - Hires Santosh Shanbhag ...

Shield Therapeutics PLC Appointment of new Chief Financial Officer

Shield Therapeutics PLC 09 January 2024 Shield Therapeutics plc ("Shield" or the "Company" or the "Group"...

TRADING UPDATES: Comptoir opens restaurant; Intercede wins contract

The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by ...

Shield Therapeutics PLC Q3 2023 U.S. Commercial Highlights

Shield Therapeutics PLC 07 December 2023 Shield Therapeutics plc ("Shield" or the "Company" or the "Group") Q3 2023...

Shield Therapeutics PLC PDMR Transaction Notification

Shield Therapeutics PLC 27 November 2023 Shield Therapeutics plc ("Shield Therapeutics" or the "Company") PDMR Transaction...

IN BRIEF: Shield Therapeutics Chief Financial Officer Rudolf to leave

cs PLC - commercial-stage pharmaceutical company focusing on its iron deficiency product Accrufer - Chief Financial Of ...

	Prix en temps réel	Carnet d'ordres
BATS Europe
Chi-X Europe
Euronext

	Prix en temps réel	Carnet d'ordres
BATS Europe
Chi-X Europe
Euronext

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Shield Therapeutics Plc (STX)

Votre Hub pour des idées et discussions en direct en temps réel

STX Actualités

Shield Therapeutics PLC Results of 2024 Annual General Meeting

TRADING UPDATES: NetScientific backs Wanda; Inspirit Energy wins deal

Shield Therapeutics PLC New Drug Application for Accrufer® in South Korea

Shield Therapeutics PLC Audited results for the year ended 31 Dec 2023

EARNINGS AND TRADING: Software Circle & Beximco report higher revenue

Shield Therapeutics PLC Business Update for Q1 2024

Shield Therapeutics PLC Notice of Results

Shield Therapeutics sinks as strong performance marred by data issues

Shield Therapeutics PLC Unaudited Full Year Trading Update

IN BRIEF: Shield Therapeutics hires former Akili leader as new CFO

Shield Therapeutics PLC Appointment of new Chief Financial Officer

TRADING UPDATES: Comptoir opens restaurant; Intercede wins contract

Shield Therapeutics PLC Q3 2023 U.S. Commercial Highlights

Shield Therapeutics PLC PDMR Transaction Notification

IN BRIEF: Shield Therapeutics Chief Financial Officer Rudolf to leave

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Vendredi fou

Jusqu'à 65% de réduction sur Intégral

Cours Euronext Niveau 1 et carnet d'ordres

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Shield Therapeutics Plc (STX) Actualités

Shield Therapeutics Plc (STX)

Votre Hub pour des idées et discussions en direct en temps réel

STX Actualités

Shield Therapeutics PLC Results of 2024 Annual General Meeting

TRADING UPDATES: NetScientific backs Wanda; Inspirit Energy wins deal

Shield Therapeutics PLC New Drug Application for Accrufer® in South Korea

Shield Therapeutics PLC Audited results for the year ended 31 Dec 2023

EARNINGS AND TRADING: Software Circle & Beximco report higher revenue

Shield Therapeutics PLC Business Update for Q1 2024

Shield Therapeutics PLC Notice of Results

Shield Therapeutics sinks as strong performance marred by data issues

Shield Therapeutics PLC Unaudited Full Year Trading Update

IN BRIEF: Shield Therapeutics hires former Akili leader as new CFO

Shield Therapeutics PLC Appointment of new Chief Financial Officer

TRADING UPDATES: Comptoir opens restaurant; Intercede wins contract

Shield Therapeutics PLC Q3 2023 U.S. Commercial Highlights

Shield Therapeutics PLC PDMR Transaction Notification

IN BRIEF: Shield Therapeutics Chief Financial Officer Rudolf to leave

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Vendredi fou

Jusqu'à 65% de réduction sur Intégral

Cours Euronext Niveau 1 et carnet d'ordres